Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03685227
Other study ID # ES62018
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 10, 2018
Est. completion date March 10, 2019

Study information

Verified date June 2019
Source National University of Natural Medicine
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study is being conducted in order to understand more about how the body responds to a mind/body practice called yoga nidra. Results from this study will be used to inform the design of future studies that investigate the effects of yoga nidra on sleep quality and insomnia.

Yoga nidra is a simple guided meditation technique that involves lying still on a mattress while listening to a voice. Participants will follow simple instructions that involve becoming aware of their body and breath, as well as various memories, emotions, and images. This practice is not religious in nature. The investigators do not believe it will conflict with any religious beliefs. The goal of this practice is to help get rid of mental, physical and emotional tensions.


Description:

This clinical trial explores the physiological effects of yoga nidra and its connection to sleep. The investigators will measure patterns in brainwave activity, respiration and heart rate variability using EEG, and two wireless devices: the Spire® breath monitor and the Bodyguard® HRV monitor. This study will also address feasibility questions related to credibility and acceptability, using self-report surveys, drop-out rates, and participant feedback. Twenty-two participants will be recruited using digital and paper advertisements throughout Portland and the National University of Natural Medicine (NUNM). Interested individuals will contact the study coordinator, and then complete a screening call. During this telephone screening, the study coordinator will ask general questions and use standardized surveys to exclude participants based on inclusion/exclusion criteria. Prospective participants who pass the telephone screening will then be invited for two visits to the Helfgott Research Institute. Each visit will involve informed consent, followed by the completion of two eligibility surveys, and several intake questionnaires. The measurement periods will involve: 10 minutes of baseline data collection, 30 minutes of lying quietly or listening to a recording of yoga nidra, and then 1 hour of resting comfortably. Participants will be allowed to fall asleep during this time and will be left alone in the room with the lights out during the entire intervention (after the first 10 minutes of baseline data collection). When finished, participants will complete a few short questionnaires before their departure. The first visit will involve lying quietly as a baseline control. At the second visit, half of the population will be randomly selected to do yoga nidra and half will complete the baseline control measurements again.


Recruitment information / eligibility

Status Completed
Enrollment 22
Est. completion date March 10, 2019
Est. primary completion date March 10, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria:

- Insomnia severity index (ISI) score 8-21 (subthreshold to moderately severe clinical insomnia)

- Can understand a recording in English

Exclusion Criteria:

- prescription sleeping medications

- regular mind/body practice within last 6 months

- diagnosed depression (or Patient Health Questionnaire (PHQ-2 into PHQ-9) score above 10)

- diagnosed sleep apnea (or STOP-BANG Sleep Apnea Questionnaire score of 3 or more)

- excessive alcohol use

- cannabis use

- smoking

- stimulant use

- shift work

- fibromyalgia

Study Design


Intervention

Other:
Yoga Nidra
This is a mind/body technique. Specifically, it is a guided meditation, performed while lying down.

Locations

Country Name City State
United States National University of Natural Medicine, Helfgott Research Institute Portland Oregon

Sponsors (3)

Lead Sponsor Collaborator
National University of Natural Medicine Oregon Health and Science University, University of Manitoba

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in EEG power (uV^2/Hz) of alpha brainwaves (defined by frequencies between 8-12 Hz) measured from the occipital region of the scalp. Average change in alpha power (from visit 1 to visit 2) will be compared for intervention and control groups. Other frequency bands (delta, beta, and theta) will be measured as well. EEG measurements will be collected from the F3, C3, and O1 locations on the scalp. 90 minutes
Secondary Change in time to sleep onset Average change in time to sleep onset (SOL) from visit 1 to visit 2, will be compared for intervention and control groups. The EEG montage follows American Academy of Sleep Medicine (AASM) guidelines for sleep measurement, and includes sensors placed in the following locations: ChinZ, Chin1, E1, E2, F3, C3, and O1, with (contralateral) reference and ground electrodes clipped onto the right and left earlobes, respectively. 90 minutes
Secondary Change in heart rate variability (HRV) parameters The average change (visit 1 to visit 2) in two HRV parameters (root mean square of successive differences between normal-to-normal intervals (RMSSD, ms); and high frequency power (HF, ms^2)) will be compared for intervention and control groups. 90 minutes
Secondary Change in respiration rate Average change in respiratory rate (visit 1 to visit 2) will be compared for intervention and control groups. 90 minutes
Secondary Feasibility: Credibility of Intervention After the intervention, participants will rate perceived credibility of the intervention for its use in producing sleep. Rating will occur immediately after their visit
Secondary Feasibility: Acceptability of Intervention Acceptability will be determined using recruitment and dropout rates Seven months
See also
  Status Clinical Trial Phase
Completed NCT04562181 - Consistency Evaluation of the qCON, qNOX Indices and Bispectral Index N/A
Recruiting NCT05487768 - Functional Connectivity After Anterior Cruciate Ligament Reconstruction N/A
Active, not recruiting NCT06443827 - Effect of Intravenous Amantadine Sulphate on Disorders of Consciousness Phase 2
Active, not recruiting NCT04455295 - Testing the Noradrenergic Hypothesis of Transcutaneous Vagus Nerve Stimulation N/A
Completed NCT04665453 - Dexmedetomidine and Melatonin for Sleep Induction for EEG in Children N/A
Active, not recruiting NCT00988702 - Shaolin Dan Tian Breathing Fosters Relaxed and Attentive Mind Phase 1/Phase 2
Recruiting NCT06084455 - TMS-evoked Potentials During Aerobic Exercise N/A
Completed NCT03330236 - EEG - Guided Anesthetic Care and Postoperative Delirium N/A
Recruiting NCT05533567 - Electroencephalographic Profiles During General Anesthesia: a Comparative Study of Remimazolam and Propofol N/A
Completed NCT05566444 - TMS-evoked Potentials During Heat Pain N/A
Completed NCT05184686 - Effects of Electromagnetic Field and Noise on Resting Electroencephalogram of Health Subjects N/A
Completed NCT00639548 - ERPS, BIS and Entropy for Neuromonitoring in ICU Patients N/A
Recruiting NCT03745963 - The Influence of Skin-to-skin Contact on Cortical Activity During Painful Procedures on Preterm Infants in the NICU Phase 3
Completed NCT04050384 - Effect of a Vibratory Stimulus on Mitigating Nociception-specific Responses to Skin Puncture in Neonates N/A
Recruiting NCT03801785 - Efficacy of Non-Nutritive Sucking (NNS) on Balance and Gait Measured in 12-42 Month-Old Healthy Children Over 36 Months N/A
Recruiting NCT03362775 - EEG Analysis During Light Propofol Sedation Phase 1
Completed NCT04472247 - Sedation Monitoring Using Frontal Electroencephalogram, Electromyogram and Hemodynamic Responses to Pain in Critical Care
Completed NCT03152331 - Nurse and Physician Stress Reduction: Learning Receptive Awareness Via EEG Feedback N/A
Completed NCT04884893 - Effect of Nitrous Oxide on EEG Phase 1
Recruiting NCT02687568 - Values of Enhanced Monitoring by EEG Recording (Narcotrend) for Sedation in Colonoscopy N/A